![Frontiers in Oncology on X: "We are happy to announce that Wafik El-Deiry of Brown University (@BrownMedicine) is joining Giuseppe Giaccone as the new co-Chief Editor for our Cancer Molecular Targets and Frontiers in Oncology on X: "We are happy to announce that Wafik El-Deiry of Brown University (@BrownMedicine) is joining Giuseppe Giaccone as the new co-Chief Editor for our Cancer Molecular Targets and](https://pbs.twimg.com/media/D54rkMVWsAEdk29.jpg)
Frontiers in Oncology on X: "We are happy to announce that Wafik El-Deiry of Brown University (@BrownMedicine) is joining Giuseppe Giaccone as the new co-Chief Editor for our Cancer Molecular Targets and
![Principles of Molecular Oncology - Foote, MaryAnn - Giaccone, Giuseppe - H. Bronchud, Miguel - I. Olopade, Olufunmilayo - Ebook in inglese - EPUB2 con Adobe DRM | IBS Principles of Molecular Oncology - Foote, MaryAnn - Giaccone, Giuseppe - H. Bronchud, Miguel - I. Olopade, Olufunmilayo - Ebook in inglese - EPUB2 con Adobe DRM | IBS](https://www.ibs.it/images/9781597454704_0_536_0_75.jpg)
Principles of Molecular Oncology - Foote, MaryAnn - Giaccone, Giuseppe - H. Bronchud, Miguel - I. Olopade, Olufunmilayo - Ebook in inglese - EPUB2 con Adobe DRM | IBS
![Cancer Chemotherapy and Biological Response Modifiers: Annual 21 : Giaccone MD PhD, Guiseppe, Schilsky MD, Richard, Sondel MD PhD, Paul: Amazon.it: Libri Cancer Chemotherapy and Biological Response Modifiers: Annual 21 : Giaccone MD PhD, Guiseppe, Schilsky MD, Richard, Sondel MD PhD, Paul: Amazon.it: Libri](https://m.media-amazon.com/images/I/81-HpetyXyL._AC_UF1000,1000_QL80_.jpg)
Cancer Chemotherapy and Biological Response Modifiers: Annual 21 : Giaccone MD PhD, Guiseppe, Schilsky MD, Richard, Sondel MD PhD, Paul: Amazon.it: Libri
![Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology](https://cdn.mdedge.com/files/s3fs-public/Giaccone_Giuseppe_DC_143563_web.jpg)
Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology
![Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University](https://gumc.georgetown.edu/wp-content/uploads/2018/11/Gia.jpg)
Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University
![Targeted Therapies in Oncology (English Edition) eBook : Giaccone, Giuseppe, Soria, Jean-Charles: Amazon.it: Kindle Store Targeted Therapies in Oncology (English Edition) eBook : Giaccone, Giuseppe, Soria, Jean-Charles: Amazon.it: Kindle Store](https://m.media-amazon.com/images/I/51-hG2A%2BFJL._SR600%2C315_PIWhiteStrip%2CBottomLeft%2C0%2C35_SCLZZZZZZZ_FMpng_BG255%2C255%2C255.jpg)
Targeted Therapies in Oncology (English Edition) eBook : Giaccone, Giuseppe, Soria, Jean-Charles: Amazon.it: Kindle Store
Dr. Giaccone on Treatment Options in NSCLC | Giuseppe Giaccone, MD, PhD, of Weill Cornell Medicine discusses current treatment options in non–small cell lung cancer. https://bit.ly/32ELJ2F | By OncLive | Facebook
![Targeted Therapies in Oncology (English Edition) eBook : Giaccone, Giuseppe, Soria, Jean-Charles: Amazon.it: Kindle Store Targeted Therapies in Oncology (English Edition) eBook : Giaccone, Giuseppe, Soria, Jean-Charles: Amazon.it: Kindle Store](https://m.media-amazon.com/images/I/51-hG2A+FJL.jpg)